The 90 million euros ($94 million) raised by Orbis Medicines in a series A round was not January’s biggest venture investment ...

Shares in US retinal diseases specialist EyePoint Pharmaceuticals recovered from an early nosedive to close trading ...

WORCESTER, Mass. - Mustang Bio , Inc. (NASDAQ:MBIO), a biopharmaceutical company engaged in the development of cell therapies for cancer treatment, has announced the pricing of a public offering ...

HelloHero, a leading provider of technology-powered mental health and behavioral care, has secured a multi-million dollar investment package from Decathlon Capital Partners. The funding will enable ...

Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from Asarina Pharma AB Phase 2a results signaled improvement ...

The United States Postal Service on Wednrsday said it would start accepting packages from China and Hong Kong again, just ...

Uncertainty about U.S. trade tariffs and persistent portfolio outflows have hurt the rupee over the last two months and made ...

LUND, SE / ACCESS Newswire / February 6, 2025 / Alligator Bioscience (STO:ATORX) FDA feedback validates the clinical ...

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on an acquisition, study results ...

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...

Burned-out doctors are ditching the operating room for the board room.